Andreas Riegler

ATMOS Space Cargo designs and manufactures space capsules to return any cargo – from below 100 kg to multiple tons – from space. Our technology will offer microgravity on demand, ranging from only 3 hours to 3 months in orbit. ATMOS will enter the market with a first demonstration mission in 2025.

Celeris Therapeutics is going to solve the R&D shortcomings as the pioneer in AI-driven PIC (proximity-inducing compounds) design using an innovative closed-loop engine (Celeris One™ platform) to develop new chemical entities (NCEs) that degrade proteins by establishing proximity to endogenous cellular mechanisms. The solutions include machine learning-driven prediction of interactions, generative design, optimization of molecular properties, and automation of laboratory devices. CelerisTx's drug pipeline is focused on CNS and oncology, targeting unmet medical needs. We also co-develop therapeutics with pharmaceutical and biotech companies. CelerisTx has so far attracted a total of EUR 18 million in committed capital from venture capital funds, which include EIC Fund, Pace Ventures Enigma, i&i biotech, Apex Ventures, R42 and longevitytech.fund. #targetedproteindegradation #degrader #ubiquitinproteasomesystem #machinelearning #CelerisOne #proximityinducingcompounds #PICs

Yuri is a world leader in commercial space biotech. We make microgravity practical for life-science R&D and future biomanufacturing - acting both as platform provider and CRO on the ISS & Haven-1. Ready to scope your payload? Let’s plan your ScienceTaxi mission or CRO study today.

Empowering everyday heroes.

kiutra has established itself as a supplier of innovative cryogenic solutions, products and services providing ultra-low temperatures. We design and build turnkey cryostats for the development, characterization, and testing of quantum systems, as well as for their continuous operation. Our systems do not require liquid cooling media, such as rare and costly helium-3, making them fast, cost-effective, and scalable.

Computer vision has made major leaps in the last few years. Mobius Labs are going a step further: it’s no longer just Computer Vision, it’s Superhuman Vision. Superhuman Vision means instantly transforming thousands of images and videos into insight, experience, and advantage. Our artificial intelligence-powered technology supercharges visual searches by understanding everything about an image or a video, and automatically creating descriptive metadata for the same. The SDK can run on cloud, local servers and edge devices (like laptops and smartphones) providing the ability to instantly understand and analyze images, video footage, and real-life scenarios. Fast, customizable and trainable with very little data, Mobius Labs AI transforms image and video archives and makes search and tagging problems a thing of the past. We believe that Vision is a power. Our goal is to add Superhuman Vision to any application, device or process, thus giving you unassailable competitive advantage. To get in touch, drop us an email at marketing@mobiuslabs.com or visit our website. Mobius Labs GmbH is receiving additional funding by the ProFIT program of the Investment Bank of Berlin. The goal of the ProFIT project “Superhuman Vision 2.0 for every application - no code, customizable, on-premise AI solutions ” is to revolutionize the work with technical images. (f.e.) This project is co-financed by the European Fund for Regional Development (EFRE). In the ProFIT project, we are exploring models that can recognize various objects and keywords in images and can also detect and segment these objects into specific pixel locations. Furthermore, we are investigating the application of ML algorithms on edge devices, including satellites, mobile phones, and tablets. Additionally, we will explore the combination of multiple modalities, such as audio embedded in videos and the language extracted from that audio.

ImageBiopsy Lab (IB Lab) is a leading digital health scale-up, providing AI-supported expertise for orthopedic surgery, musculoskeletal (MSK) radiology and affected patients alike. We are a group of physicians, software engineers and entrepreneurs, passionate about our cause to find optimal solutions to complex medical needs through the latest technological innovations. Our vision is to become the One-Stop-Shop for musculoskeletal imaging intelligence, enabling new medical standards for 1.7B patients being affected. What differentiates IB Lab from other AI-supported medical companies is our clear focus to go beyond diagnostics, turning large amounts of unstructured imaging data into meaningful evidence.

contextflow is your comprehensive solution for all things chest CT: lung cancer, ILD and COPD. Our computer-aided detection system ADVANCE Chest CT offers lung nodule detection & tracking of changes over time, quantitative and qualitative analysis of 8 key image patterns, and 3D image search for 19 image patterns. By integrating new technology from partner RevealDx, nodules can be further characterized, detecting lung cancer earlier and reducing costs (JACR 9/22). contextflow ADVANCE Chest CT includes a TIMELINE feature that even quantifies and visualizes nodules over time, allowing physicians to follow treatment progress easily and efficiently. Fully integrated into the radiologists workflow, our preliminary research shows average reading time is 31% shorter when contextflow SEARCH is available for use (European Radiology July 2022). Coming soon in 2023: incidental pulmonary embolism. contextflow is a spin-off of the Medical University of Vienna (MUW), Technical University of Vienna (TU) and European research project KHRESMOI. Founded by myself and 3 other AI and medical imaging experts in July 2016, we were awarded the distinction of Most Promising Startup by the BCS Search Industry and received the Digital Innovation Award by the Austrian Federal Ministry of Education, Science and Research that same year. In 2018, we were selected as one of 19 startups out of 700+ applications to participate in the Philips HealthWorks accelerator program and were named Top HealthTech Company - Austria for the 2019 Central Eastern Startup Awards. Forbes DACH listed us as one of the top AI30 startups in 2020, and the Austrian Chamber of Commerce named us a Born Global Champion in 2021. Twitter: @contextflow_rad Youtube: https://www.youtube.com/channel/UCTvdkGwlHio0vKfhvqQT_UA Sign up for our newsletter: contextflow.ac-page.com/newsletter-sign-up

We believe insurance companies should reward customers for buying safer cars and driving them in a safer way. Our mission: enabling the safety, value and freedom that comes with autonomous driving.

We believe insurance companies should reward customers for buying safer cars and driving them in a safer way. Our mission: enabling the safety, value and freedom that comes with autonomous driving.

KIVU Technologies provides innovative graph computing solutions for security investigators and analysts. KIVU enables security analysts to maximise intelligence value and save mission-critical time. KIVU’s scalable software reduces the complexity of connected data problems, enabling customers to uncover insights from complex, multi-attribute data – previously hidden or overlooked by conventional analytics. Established in 2016, KIVU is forging a new future for big data, disrupting the existing data management platforms and providing with clients with vital, intelligent and reliable real-time analysis.

HAAWK (Helping All Assets With Knowledge) monitors and enforces rights across UGC video platforms including YouTube, Facebook, Vimeo, and more. We administer YouTube's Content ID system, Facebook Rights Manager, and other copyright monitoring products and services on behalf of record labels, music publishers, production music libraries, film/TV studios, and other copyright holders. HAAWK offers both full service and do-it-yourself (DIY) rights management solutions. Our DIY product, Identifyy (http://identifyy.com), offers a quick a simply solution to upload your recordings as access our suite of services. HAAWK’s roster of clients includes independent record labels, music publishers, songwriters and composers, DIY artists, TV and film studios, and production music libraries. For more information, visit http://haawk.com and http://identifyy.com They're your copyrights, use your claws.

Stroke is the most common neurological diagnosis. Every year, 15 million people suffer a stroke worldwide, and a third of them have impairments of motor function, speech and vision. Many stroke affected cannot use their arm in everyday life, and this hugely affects their quality of life. Independent training for hand rehabilitation most commonly consists of mirror therapy and observation of movement. These methods, however, are not very adaptable to the specific needs of the patient. Combining virtual reality and gesture control can compensate these shortcomings, moving the evidence based approaches of mirror therapy and observation of movements from the real to the virtual world. Rewellio offers a training option that can be used at home, as well as in therapeutic communities, care facilities and rehabilitation centers, because of readily available mobile VR hardware. Our goal is to support stroke patients on their difficult journey of rehabilitation in an affordable, easily accessible and effective way.

Stroke is the most common neurological diagnosis. Every year, 15 million people suffer a stroke worldwide, and a third of them have impairments of motor function, speech and vision. Many stroke affected cannot use their arm in everyday life, and this hugely affects their quality of life. Independent training for hand rehabilitation most commonly consists of mirror therapy and observation of movement. These methods, however, are not very adaptable to the specific needs of the patient. Combining virtual reality and gesture control can compensate these shortcomings, moving the evidence based approaches of mirror therapy and observation of movements from the real to the virtual world. Rewellio offers a training option that can be used at home, as well as in therapeutic communities, care facilities and rehabilitation centers, because of readily available mobile VR hardware. Our goal is to support stroke patients on their difficult journey of rehabilitation in an affordable, easily accessible and effective way.

Mush makes the most out of motherhood. Providing pods of friendship and experiences for new mums through the app, and supporting employers to provide the best maternity experience for their employees on maternity leave, Mush knows mums. Being a mum is many amazing things (and plenty of challenging things too); at Mush we passionately believe that every mum needs a local group of mum friends to share the crazy journey of parenting with. Launched in 2016, Mush is frequently named as one of the top apps for mums by Apple, Google and the national press. We were recently listed in Wired 'Top 100 European Startups'​ report as one of 10 selected London startups. Mums use Mush to find local friends with kids the same age, ask advice from local mums, look up kid friendly places to go and read funny, reassuring articles. All in the name of making being a mum more fun. Our vision is to connect mums to their local community so every mum can feel more confident in what they are doing.

ATMOS Space Cargo designs and manufactures space capsules to return any cargo – from below 100 kg to multiple tons – from space. Our technology will offer microgravity on demand, ranging from only 3 hours to 3 months in orbit. ATMOS will enter the market with a first demonstration mission in 2025.

Celeris Therapeutics is going to solve the R&D shortcomings as the pioneer in AI-driven PIC (proximity-inducing compounds) design using an innovative closed-loop engine (Celeris One™ platform) to develop new chemical entities (NCEs) that degrade proteins by establishing proximity to endogenous cellular mechanisms. The solutions include machine learning-driven prediction of interactions, generative design, optimization of molecular properties, and automation of laboratory devices. CelerisTx's drug pipeline is focused on CNS and oncology, targeting unmet medical needs. We also co-develop therapeutics with pharmaceutical and biotech companies. CelerisTx has so far attracted a total of EUR 18 million in committed capital from venture capital funds, which include EIC Fund, Pace Ventures Enigma, i&i biotech, Apex Ventures, R42 and longevitytech.fund. #targetedproteindegradation #degrader #ubiquitinproteasomesystem #machinelearning #CelerisOne #proximityinducingcompounds #PICs

Yuri is a world leader in commercial space biotech. We make microgravity practical for life-science R&D and future biomanufacturing - acting both as platform provider and CRO on the ISS & Haven-1. Ready to scope your payload? Let’s plan your ScienceTaxi mission or CRO study today.

Empowering everyday heroes.

kiutra has established itself as a supplier of innovative cryogenic solutions, products and services providing ultra-low temperatures. We design and build turnkey cryostats for the development, characterization, and testing of quantum systems, as well as for their continuous operation. Our systems do not require liquid cooling media, such as rare and costly helium-3, making them fast, cost-effective, and scalable.